Silver Book Fact

To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type 2 diabetes. 

Spiegel A, Hawkins M. ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?. Health Affairs. 2012; 31(1): 43-49. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.1054?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Spiegel A, Hawkins M
Volume & Issue
Volume 31, Issue 1
Pages
43-49
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Every additional dollar spent on intensive blood glucose control for newly diagnosed type 2 diabetic patients has produced health gains valued at $3.77.  
  • The use of insulin pumps create net cost savings, including $5886 annually per person affected and $34.9 million in increased tax revenue  
  • To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type…  
  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring, and collaborative drug therapy management…